University Hospital of Northern Norway
Welcome,         Profile    Billing    Logout  
 10 Trials 
24 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Klingenberg, Claus
INSTAR, NCT03889743 / 2015-001077-40: Innovative Steroid Treatment to Reduce Asthma Development in Children After First-time Rhinovirus Induced Wheezing

Recruiting
4
280
Europe
Dexamethasone treatment during 3 days, placebo treatment during 3 days, lactose
St. Olavs Hospital, Turku University Hospital, Karolinska University Hospital, Haukeland University Hospital, University Hospital, Akershus, Helse Stavanger HF, University Hospital of North Norway, Ullevaal University Hospital
Asthma, Inflammation
05/26
05/28
AMIC, NCT06020716: Antibiotics, Microbiology and Immunology in Children With Chronic Wet Cough - the Study

Recruiting
4
350
Europe
Amoxicillin-Clavulanate 400 Mg-57 Mg/5 mL Oral Powder for Reconstitution, Placebo
Helse Stavanger HF, Oslo University Hospital, Haukeland University Hospital, Alesund Hospital, University Hospital, Akershus, Trondheim University Hospital, University Hospital of North Norway
Protracted Bacterial Bronchitis
04/28
04/28
OPTIMIST, NCT05794945: Optimizing Mastitis Identification and Treatment

Recruiting
N/A
500
Europe
University of Tromso, Norwegian Institute of Public Health, The University of Western Australia, Helse Nord
Mastitis Postpartum
01/25
06/27
Bakland, Gunnstein
NCT03704363: BackToBasic: Infliximab in Chronic Low Back Pain and Modic Changes

Completed
3
128
Europe
Biosimilar Infliximab, Placebo, NaCl intravenous infusion
Oslo University Hospital, Haukeland University Hospital, St. Olavs Hospital, University Hospital of North Norway, Vestre Viken Hospital Trust, Ostfold Hospital Trust, Clinical Trial Unit (CTU), Oslo University Hospital, Diakonhjemmet Hospital
Low Back Pain
07/23
09/23
MicroSpA, NCT06451588: Fecal Microbiota Transplantation in Axial Spondyloarthritis

Recruiting
2
99
Europe
FMT, Placebo
University Hospital of North Norway, Helse Nord
Axial Spondyloarthritis, Ankylosing Spondylitis, Dysbiosis, Spondyloarthritis, Spondylitis, Arthritis, Musculoskeletal Diseases, Spinal Disease, Joint Diseases
05/25
03/26
NOR-SPRINT, NCT05291819: Imaging Treat-to-target Strategy vs Conventional Treat-to-target Strategy in Psoriatic Arthritis

Recruiting
N/A
202
Europe
Imaging informed treat-to-target, Conventional treat-to-target
Diakonhjemmet Hospital
Psoriatic Arthritis
12/27
12/27
ARCTIC-FORWARD, NCT05304013: 10-year Follow-up of Patients With Rheumatoid Arthritis Who Received Structured Treat-to-target Therapy in Early Disease

Completed
N/A
180
Europe
Diakonhjemmet Hospital
Rheumatoid Arthritis
08/24
08/24
RIMRA, NCT05544292: Rheumatic IMmune-Related Adverse Events in Patients Treated With Immune Check Point Inhibitors

Active, not recruiting
N/A
80
Europe
Antiinflammatory/DMARDs
Diakonhjemmet Hospital, Oslo University Hospital, Alesund Hospital, University Hospital of North Norway, Hospital of Southern Norway Trust, Helse Nord-Trøndelag HF
Immune-related Adverse Event
12/25
12/25
Blix, Egil
NCT02965950 / 2016-003459-31: The p53 Breast Cancer Trial

Active, not recruiting
2
190
Europe
Cyclophosphamide, ATC-number: L01A A01
Haukeland University Hospital
Locally Advanced Breast Cancer, Metastatic Breast Carcinoma
05/24
05/33
PRADAII, NCT03760588: Prevention of Cardiac Dysfunction During Breast Cancer Therapy

Active, not recruiting
2
214
Europe
Sacubitril/valsartan, Entresto®
Torbjorn Omland, University Hospital, Akershus, Oslo University Hospital, University Hospital of North Norway, St. Olavs Hospital, Helse Stavanger HF, Klinbeforsk, Norwegian Cancer Society, Novartis
Breast Cancer Female, Heart Failure
09/24
09/25
IMPRESS-Norway, NCT04817956 / 2020-004414-35: Improving Public Cancer Care by Implementing Precision Medicine in Norway

Recruiting
2
3000
Europe
Atezolizumab, Atezolizumab combined with bevacizumab, Phesgo (trastuzumab og pertuzumab), Alectinib, vismodegib, entrectinib, Vemurafenib and cobemitinib, Niraparib, Dostarlimab, Ceritinib
Oslo University Hospital, Haukeland University Hospital, St. Olavs Hospital, University Hospital of North Norway, University Hospital, Akershus, Vestre Viken Hospital Trust, Hospital of Southern Norway Trust, Ostfold Hospital Trust, The Hospital of Vestfold, Helse Stavanger HF, Nordlandssykehuset HF, Sykehuset Innlandet HF, Helse Forde, Helse Fonna HF, Helse Nord-Trøndelag HF, Helse Møre og Romsdal HF, Sykehuset Telemark, Lovisenberg Diakonale Hospital
Cancer Metastatic
03/40
04/45
NCT02384733: Hypofractionated Loco-regional Adjuvant Radiation Therapy of Breast Cancer Combined With a Simultaneous Integrated Boost

Active, not recruiting
N/A
2963
Europe
Loco-regional RT
Danish Breast Cancer Cooperative Group, Danish Cancer Society
Lymphedema, Fibrosis
07/21
07/32
Kalstad, Synøve
NOR-DMARD, NCT01581294: The Norwegian Antirheumatic Drug Register

Recruiting
N/A
15000
Europe
Diakonhjemmet Hospital, University Hospital of North Norway, St. Olavs Hospital, Lillehammer Hospital for Rheumatic Diseases, Vestre Viken Hospital Trust, Helse Forde
Inflammatory Joint Diseases
12/50
12/50
Haugnes, Hege S
PEACE III, NCT02194842 / 2014-001787-36: Phase III Radium 223 mCRPC-

Active, not recruiting
3
446
Europe, Canada, RoW
Ra223, Enzalutamide
European Organisation for Research and Treatment of Cancer - EORTC, Bayer, Astellas Pharma Europe Ltd., UNICANCER, Canadian Urologic Oncology Group, Latin American Cooperative Oncology Group, Cancer Trials Ireland
Prostate Cancer
02/24
12/28
ProBio, NCT03903835 / 2018-002350-78: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer

Recruiting
3
750
Europe
Enzalutamide Oral Capsule, Xtandi, Abiraterone Oral Tablet, Zytiga, Carboplatin, Cabazitaxel 60 mg Solution for Injection, Docetaxel Injectable Solution, Radium Chloride Ra-223, Xofigo, Niraparib plus Abiraterone acetate plus Prednisone, Akeega, Capivasertib plus Docetaxel, Apalutamide, Erleada, Darolutamide, Nubeqa
Karolinska Institutet, The Swedish Research Council, Kom Op Tegen Kanker, Janssen Pharmaceutica N.V., Belgium, AstraZeneca, Cancerfonden
Metastatic Castration-resistant Prostate Cancer (mCRPC), Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
12/26
12/26
GrandP/SPCG19, NCT05448547: Immediate Curative Vs Conservative Treatment in Older Men with M0, High-risk Prostate Cancer

Recruiting
3
980
Europe
Radiotherapy or surgery, initial observation, Hormone therapy
Sven Löffeler, Oslo University Hospital, Klinbeforsk
Prostate Cancer
12/29
12/36
NCT04298112: PSMA-PET and MRI for Detection of Recurrent Prostate Cancer After Radical Treatment

Completed
N/A
300
Europe
PSMA PET/CT, PSMA PET/MR
Norwegian University of Science and Technology, Haukeland University Hospital, University Hospital of North Norway, St Olavs Hospital University Hospital in Trondheim
Prostatic Neoplasms
05/23
05/23
NCT04790968: Combined PSMA PET/MRI for Detection of Lymph Node Metastases in High-risk Prostate Cancer Patients

Completed
N/A
90
Europe
PSMA-PET, PSMA-PET/MRI, PSMA-PET/CT
Norwegian University of Science and Technology, St. Olavs Hospital, Haukeland University Hospital, University Hospital of North Norway
Prostatic Neoplasms, Neoplasm Metastasis
09/24
09/24
NCT04914026: MicroRNA as Markers in Testicular Cancer

Recruiting
N/A
350
Europe
Biomarker analysis
Haukeland University Hospital, Karolinska University Hospital, Sahlgrenska University Hospital, Sweden, Helse Fonna, University Hospital of North Norway, Oslo University Hospital
Testicular Germ Cell Cancer, Seminoma, Non-Seminoma Testicular Cancer, Stage I Testicular Cancer, Stage II Testicular Cancer, Stage III Testicular Cancer, Stage IV Testicular Cancer, Relapse Testicular Cancer
12/26
12/26
Aahlin, Eirik Kjus
NCT04460352 / 2020-000149-15: Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer

Recruiting
3
1020
Europe, Canada
Neoadjuvant radiotherapy (arm A), Carboplatin, paclitaxel, Neoadjuvant chemotherapy, Esophagectomy, Neoadjuvant radiotherapy (arm B), Neoadjuvant Platin-Taxane Regimen (alternative 1), Cisplatin, paclitaxel, Platinum-Fluoropyrimidine Regimens (alternative 2a), Oxaliplatin, calcium folinate, 5-fluorouracil, Platinum-Fluoropyrimidine Regimens (alternative 2b)
Karolinska University Hospital, University of Leipzig, The Swedish Research Council
Esophageal Squamous Cell Carcinoma
09/26
12/31
SARONG-II, NCT06115629: Surveillance After Resection of Oesophageal aNd Gastric Cancer () Trial

Not yet recruiting
3
952
Europe
Surveillance protocol
University of Dublin, Trinity College, Trinity St. James's Cancer Institute, University of Oxford, Karolinska Institutet
Esophageal Cancer, Gastric Cancer
11/26
11/29
Thon, Kristian
GrandP/SPCG19, NCT05448547: Immediate Curative Vs Conservative Treatment in Older Men with M0, High-risk Prostate Cancer

Recruiting
3
980
Europe
Radiotherapy or surgery, initial observation, Hormone therapy
Sven Löffeler, Oslo University Hospital, Klinbeforsk
Prostate Cancer
12/29
12/36
Lindtjorn, Birger
NCT06211907: Small Macular Holes Treated With Air

Recruiting
N/A
132
Europe
Postoperative intraocular tamponade
Helse Stavanger HF, Haukeland University Hospital, St. Olavs Hospital, Trondheim, Norway, Oslo University Hospital, Oslo, Norway, University Hospital of Northern Norway, Tromsø, Norway, University of Stavanger, Royal Liverpool University Hospital, Bangor University, Qwynedd, UK, McGill University, University Hospital Complex of Santiago de Compostela, Galicia, Spain
Macular Holes
06/28
06/28
Dervenis, Nikolaos
NCT06211907: Small Macular Holes Treated With Air

Recruiting
N/A
132
Europe
Postoperative intraocular tamponade
Helse Stavanger HF, Haukeland University Hospital, St. Olavs Hospital, Trondheim, Norway, Oslo University Hospital, Oslo, Norway, University Hospital of Northern Norway, Tromsø, Norway, University of Stavanger, Royal Liverpool University Hospital, Bangor University, Qwynedd, UK, McGill University, University Hospital Complex of Santiago de Compostela, Galicia, Spain
Macular Holes
06/28
06/28

Download Options